Molecular Mechanics Calculations on Protein-Ligand Complexes

Perspectives in Drug Discovery and Design

Volumn 9, Issue , 1998, Pages 115-127

  Weber, Irene T ^a   Harrison, Robert W ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0008878905     PISSN: 09282866     EISSN: None     Source Type: Journal    
DOI: 10.1007/0-306-46857-3_7     Document Type: Article

References (26)

1. Briggs, J.M., Marrone, T.J. and McCammon, J.A., Computational science new horizons and relevance to pharmaceutical design, Trends Cardiovasc. Med., 6 (1996) 198-204.
2. Weber, I.T., and Harrison, R.W., Molecular mechanics calculations on HIV-1 protease with peptide substrates correlate with experimental data, Protein Eng., 9 (1996) 679-690.
3. Xu, L.Z., Weber, I.T., Harrison, R.W., Gidh-Jain, M. and Pilkis, S.J., Sugar specificity of human β-cell glucokinase: Correlation of molecular models with kinetic measurements, Biochemistry, 34 (1995) 6083-6092.
4. Holloway, M.K., Wai, J.M., Halgren, T.A., Fitzgerald, P.M., Vacca, J.P., Dorsey, B.D., Levin, R.B., Thompson, W.J., Chen, L.J., deSolms, S.J., Gaffin, N., Ghosh, A.K., Giuliani, E.A, Graham, S.L., Guare, J.P., Hungate, R.W., Lyle, T.A., Sanders, W.M., Tucker, T.J., Wiggins, M., Wiscount, C.M., Woltersdorf, O.W., Young, S.D., Darke, P.L. and Zugay, J.A. A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site, J. Med. Chem., 38 (1995) 305-317.
5. Head, R.D., Smythe, M.L., Oprea, T.I., Waller, C.L., Green, S.M. and Marshall, G.R., VALIDATE: A new method for the receptor-based prediction of binding affinities of novel ligands, J. Am. Chem. Soc., 118 (1996) 3959-3969.
6. Harrison, R.W., Stiffness and energy conservation in the molecular dynamics: An improved integrator, J. Comp. Chem., 14 (1993) 1112-1122.
7. Kourinov, I. and Harrison, R.W., Prediction of novel serine proteinase inhibitors, Nature Struc. Biol., 1 (1994) 735-743.
8. Harrison, R.W., and Weber, I.T., Molecular dynamics simulation of HIV-1 protease with peptide substrate, Protein Eng., 7 (1994) 1353-1363.
9. Harrison, R.W., Chatterjee, D. and Weber, I.T. Analysis of six protein structures predicted by comparative modeling techniques, Proteins: Struct. Funct. Genet., 23 (1995) 463-471.
10. Weiner, S.J., Kollman, P.A., Nguyen, D.T. and Case, D.A., An all atom force field for simulations of proteins and nucleic acids, J. Comput. Chem., 7 (1986) 230-252.
11. Allinger, N.L., Yuh, Y.H. and Lu, J.-H., Molecular mechanics: The MM3 force field for hydrocarbons, J. Am. Chem. Soc., 111 (1989) 8551-8565.
12. Rappe, A.K., Casewit, C.J., Colwell, K.S., Goddard, W.A., III, and Skiff, W.M., UFF: A full periodic table force field for molecular mechanics and molecular dynamics simulations, J. Am. Chem. Soc., 114 (1992) 10024-10035.
13. Schreiber, H. and Steinhauser, O., Cutoff size does strongly influence molecular dynamics results on solvated polypeptides, Biochemistry, 31 (1992) 5856-5860.
14. Greengard, L. and Rokhlin, V., A fast algorithm for particle simulations, J. Comp. Phys., 73 (1987) 325-348.
15. Harrison, R.W., Kourinov, I.V. and Andrews, L.C. The Fourier Green's function and the rapid evaluation of molecular potentials, Protein Eng., 7 (1994) 359-369.
16. Zeng, C.B., Aleshin, A.E., Hardie, J.B., Harrison, R.W. and Fromm, H.J., ATP-binding site of human brain hexokinase as studied by molecular modeling and site-directed mutagenesis, Biochemistry, 35 (1996) 13157-13164.
17. Wlodawer, A., Nachman, J., Gilliland, G.L., Gallagher, W. and Woodward, C., Structure of form III crystals of bovine pancreatic trypsin inhibitor, J. Mol. Biol., 198 (1987) 469-480.
18. Zegers, I., Maes, D., Dao-Thi,M.-H., Poortmans, F., Palmer, R. and Wyns, L. The structures of RNase A complexed with 3′CMP and d(CpA): Active site conformation and conserved water molecules, Protein Science. 3 (1994) 2322-2339.
19. Fersht, A., Enzyme structure and mechanism, W.H. Freeman and Company, New York, 1985.
20. Darke, P.L., Nutt, R.F., Brady, S.F., Garsky, V.M., Ciccarone, T.M., Leu, C.T., Lumma, P.K., Freidinger, R.M., Vebal, D.F. and Sigal, I.S., HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins, Biochem. Biophys. Res. Commun., 156 (1988) 297-303.
21. Polgar. L., Szeltner, Z. and Boros, I., Substrate-dependent mechanisms in the catalysis of human immunodeficiency virus protease, Biochemistry, 33 (1994) 9351-9357.
22. Hyland, L.J., Tomaszek, T.A. and Meek, T.D., Human immunodeficiency virus-1 protease: 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanisms, Biochemistry, 30 (1991) 8454-8463.
23. Oprea, T.I., Waller, C.L. and Marshall, G.R., Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors: 2. Predictive power using limited exploration of alternate binding modes, J. Med. Chem., 37 (1994) 2206-2215.
24. Beveridge, D.L. and DiCapua, P.M., Free energy via molecular simulation: applications to chemical and biomolecular systems, Ann. Rev. Biophys. Biophys. Chem., 18 (1989) 431-492.
25. Goldenfeld, N., Lectures on phase transitions and the renormalization group, Vol. 85, Frontiers in Physics, Addison-Wesley, Reading, MA, 1992.
26. Reed, C., Fu, Z.-Q., Wu, J., Xue, Y.-N., Harrison, R.W., Chen, M.-J. and Weber, I.T. Crystal structure of TNF-α mutant R3ID with greater affinity for receptor R1 compared to R2, Protein Eng. 10 (1997) 101-107.